We next used an independent validation dataset on RNAseq-based mRNA profiles and matched the survival data of 47 DLBCL patients from the TCGA project that were available to further evaluate the prognostic effect of high-level EGFR/ERBB1 mRNA expression. The gene discussed is EGFR; the disease is diffuse large B-cell lymphoma.